Health plans requirement to cover infertility treatment and standard fertility preservation services
SF3615 would require Minnesota health plans that provide maternity benefits to cover the diagnosis and treatment of infertility, as well as standard fertility preservation services. The bill defines infertility broadly, including inability to conceive after a specified period, inability to reproduce without medical intervention, or a provider’s clinical determination. It also requires coverage for fertility preservation when a person faces medical treatment or conditions likely to impair fertility, such as chemotherapy, radiation, surgery, or certain medications.
The bill sets several coverage rules. Health plans would have to include unlimited embryo transfers, may limit completed oocyte retrievals to four, and may not require cost-sharing greater than what the plan imposes for maternity coverage. It also bars benefit caps, waiting periods, utilization review, referral requirements, and other restrictions that are not generally applicable to maternity coverage. Surgical reversal of elective sterilization is expressly excluded from the required benefit. The bill would take effect January 1, 2027, and apply to plans issued or renewed on or after that date.
The bill would also amend Minnesota’s religious-objection provisions so that exempt organizations and eligible organizations can continue to decline coverage for infertility treatment and related reproductive health benefits on religious grounds, subject to notice requirements. In addition, it would require the commissioner of commerce to reimburse health plan companies for the new mandated coverage and would appropriate general fund money beginning in fiscal year 2028 to defray those costs, including administrative expenses.
For public programs, the bill would require Medical Assistance and MinnesotaCare to cover infertility treatment and standard fertility preservation services, with the Medical Assistance provision limited to what is compatible with federal funding and access requirements. It also amends the Medical Assistance drug coverage statute to clarify that fertility drugs are not covered when specifically used to enhance fertility, while adding a new infertility-treatment coverage subdivision. The bill includes appropriations for both Medical Assistance and MinnesotaCare to support the new benefits, though the dollar amounts are left blank in the introduced version.
Because there are no committee transcripts or recorded votes in the provided materials, there is no documented debate or formal vote history to gauge sentiment. Based on the bill text alone, the measure appears to be a broad benefit-expansion proposal aimed at improving access to infertility care and fertility preservation, while preserving religious exemptions and creating a state reimbursement mechanism for insurers.
The bill would create a new insurance mandate in Minnesota Statutes chapter 62Q requiring most health plans that cover maternity benefits to cover infertility diagnosis and treatment and standard fertility preservation services. It would also amend the state’s religious-objection statute to include the new infertility coverage mandate, and it would add corresponding coverage requirements for Medical Assistance and MinnesotaCare, subject to federal approval and funding constraints. The bill further establishes a state reimbursement/defrayal structure through the commissioner of commerce and appropriates funds to support the mandate’s costs for both private plans and public programs.
No committee testimony or vote record was provided, so there is no direct evidence of legislative support or opposition in the materials. The bill’s structure suggests a policy goal of expanding reproductive health coverage, which is typically viewed favorably by advocates for infertility access and fertility preservation. At the same time, the inclusion of religious exemptions, cost-defrayal payments, and federal-approval contingencies indicates the sponsor anticipated concerns from insurers, employers, and public-program administrators about cost, administration, and conscience protections.
The main likely points of contention are cost, scope, and religious accommodation. Health plans and employers may object to the mandate’s breadth, including unlimited embryo transfers, limits on cost-sharing, and the prohibition on many utilization controls. Religious organizations may focus on whether the amended exemption language adequately protects their ability to decline coverage. Public-program administrators may also be concerned about whether the new Medical Assistance and MinnesotaCare benefits can be implemented without jeopardizing federal matching funds or reducing access for enrollees. The bill’s reimbursement and appropriation provisions appear designed to address insurer cost concerns, but the actual fiscal impact is left unresolved in the introduced text because the appropriation amounts are blank.